$102.26
0.010.01%
À la clôture: Jan 14, 4:00 PM EST
$102.26
N/A
Après les heures: 4:00 PM EST
Comments
Loading...
Exact Sciences Activité de délit d'initié
EXASNASDAQ
Activité de trading des initiés
Suivez les dernières activités de délit d'initié Exact Sciences. Restez informé des achats, des ventes et de l'impact sur le marché des actions Exact Sciences.
Qu’est-ce que l’activité d’initié ?
L'activité de délit d'initié implique des initiés de l'entreprise, tels que des dirigeants, des administrateurs et des employés, qui s'engagent dans des transactions sur les actions de leur propre entreprise. Les transactions d'achat et de vente des initiés fournissent des informations précieuses sur leur confiance dans les performances futures de l'entreprise.
Que font les Exact Sciences Corp Insiders ?
Les initiés n’ont signalé aucun achat/vente au cours des 30 derniers jours.
Achats et ventes récents notables d’initiés
- Le novembre 21, 2025 James Herriott, le SVP, GENERAL COUNSEL & SEC sold 1K actions pour $70 chacune.
- Le novembre 6, 2025 James Herriott, le SVP, GENERAL COUNSEL & SEC sold 1.5K actions pour $70.08 chacune.
- Le novembre 6, 2025 Brian Baranick, le EVP, GM, PRECISION ONCOLOGY sold 2.86K actions pour $70.08 chacune.
Statistiques de propriété pour Exact Sciences Corp
Actions en circulation
189.766M
Actions détenues par les initiés
3.934M
Pourcentage d'actions détenu par les initiés
2.07%
Actions détenues par les institutions
120.501M
Pourcentage d'actions détenu par les institutions
63.4%
| Nov 21, 2025 | Jacob A Orville | EVP, GM, SCREENING | -5.00K | $75.00 | -$375.00K | SELL | -16.82% | 24.73K | Nov 19 | View |
| Nov 21, 2025 | James Herriott | SVP, GENERAL COUNSEL & SEC | -1.00K | $70.00 | -$70.00K | SELL | -7.07% | 13.14K | Nov 19 | View |
| Nov 06, 2025 | James Herriott | SVP, GENERAL COUNSEL & SEC | -1.50K | $70.08 | -$105.12K | SELL | -9.59% | 14.14K | Nov 04 | View |
| Nov 06, 2025 | Brian Baranick | EVP, GM, PRECISION ONCOLOGY | -2.86K | $70.08 | -$200.29K | SELL | -11.04% | 23.04K | Nov 04 | View |
| Oct 27, 2025 | Katherine S Zanotti | — | -12.00K | $65.00 | -$780.00K | SELL | -16.49% | 60.76K | Oct 24 | View |
| Oct 10, 2025 | James Herriott | SVP, GENERAL COUNSEL & SEC | -1.50K | $60.00 | -$90.00K | SELL | -8.75% | 15.64K | Oct 09 | View |
| Oct 10, 2025 | James Edward Doyle | — | -2.00K | $60.00 | -$120.00K | SELL | -3.34% | 57.96K | Oct 09 | View |
| Aug 14, 2025 | James Edward Doyle | — | -1.49K | $42.02 | -$62.40K | SELL | -2.42% | 59.96K | Aug 13 | View |
| Jun 16, 2025 | Katherine S Zanotti | — | 2.19K | $53.20 | -$170.61K | GRANT | 3.10% | 72.76K | Jun 12 - Jun 13 | View |
| Nov 13, 2024 | Kevin T Conroy | PRESIDENT AND CEO | 19.50K | $51.35 | $1.00M | BUY | 1.69% | 1.18M | Nov 13 | View |
| Oct 09, 2024 | Brian Baranick | EVP, GM, PRECISION ONCOLOGY | -929.00 | $70.00 | -$65.03K | SELL | -6.57% | 13.21K | Oct 08 | View |
| Sep 19, 2024 | Brian Baranick | EVP, GM, PRECISION ONCOLOGY | -929.00 | $70.00 | -$65.03K | SELL | -6.16% | 14.14K | Sep 18 | View |
| May 02, 2024 | D. Scott Coward | — | 151.00 | $60.15 | -$4.03K | GRANT | 0.31% | 49.34K | Apr 30 - May 01 | View |
| May 02, 2024 | Everett Cunningham | CHIEF COMMERCIAL OFFICER | 863.00 | $45.09 | $13.07K | GRANT | 1.85% | 47.61K | Apr 30 - May 01 | View |
| May 02, 2024 | James Herriott | SVP, GENERAL COUNSEL & SEC | 741.00 | $45.09 | $19.45K | GRANT | 7.19% | 11.05K | Apr 30 - May 01 | View |
| May 02, 2024 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 862.00 | $45.09 | $13.04K | GRANT | 6.89% | 13.38K | Apr 30 - May 01 | View |
| May 02, 2024 | Brian Baranick | EVP, GM., PRECISION ONCOLOGY | 108.00 | $60.15 | -$6.62K | GRANT | 0.79% | 13.73K | Apr 30 - May 01 | View |
| May 02, 2024 | Sarah Condella | EVP, HUMAN RESOURCES | 824.00 | $45.09 | $15.12K | GRANT | 1.06% | 78.34K | Apr 30 - May 01 | View |
| May 02, 2024 | Jacob A Orville | GENERAL MANAGER, SCREENING | 116.00 | $60.15 | -$6.14K | GRANT | 0.75% | 15.56K | Apr 30 - May 01 | View |
| May 02, 2024 | Kevin T Conroy | PRESIDENT AND CEO | 2.04K | $45.09 | -$48.22K | GRANT | 0.17% | 1.18M | Apr 30 - May 01 | View |
| Apr 03, 2024 | Sarah Condella | EVP, HUMAN RESOURCES | -2.00K | $70.00 | -$140.00K | SELL | -2.52% | 77.51K | Apr 01 | View |
| Apr 03, 2024 | Brian Baranick | EVP, GM., PRECISION ONCOLOGY | -924.00 | $79.43 | -$73.39K | SELL | -6.35% | 13.63K | Apr 02 | View |
| Apr 01, 2024 | Sarah Condella | EVP, HUMAN RESOURCES | -2.00K | $70.00 | -$140.00K | SELL | -2.45% | 79.51K | Mar 28 | View |
| Mar 04, 2024 | Jacob A Orville | GENERAL MANAGER, SCREENING | 2.57K | $59.32 | -$127.78K | SELL-OPTIONS | 19.97% | 15.44K | Feb 29 - Mar 01 | View |
| Mar 04, 2024 | Daniel J Levangie | DIRECTOR | -5.00K | $57.50 | -$287.50K | SELL | -17.87% | 22.98K | Mar 01 | View |
| Mar 04, 2024 | James Herriott | GENERAL COUNSEL | 1.03K | $59.32 | -$51.13K | SELL-OPTIONS | 11.08% | 10.31K | Feb 29 - Mar 01 | View |
| Mar 04, 2024 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 2.88K | $59.32 | -$143.08K | SELL-OPTIONS | 29.87% | 12.52K | Feb 29 - Mar 01 | View |
| Mar 04, 2024 | James Edward Doyle | DIRECTOR | -2.00K | $57.50 | -$115.00K | SELL | -3.84% | 50.11K | Mar 01 | View |
| Mar 04, 2024 | Everett Cunningham | CHIEF COMMERCIAL OFFICER | 2.88K | $59.32 | -$143.08K | SELL-OPTIONS | 6.56% | 46.75K | Feb 29 - Mar 01 | View |
| Mar 04, 2024 | Kevin T Conroy | PRESIDENT AND CEO | 9.87K | $59.32 | -$490.64K | SELL-OPTIONS | 0.75% | 1.32M | Feb 29 - Mar 01 | View |
| Mar 04, 2024 | Sarah Condella | EVP, HUMAN RESOURCES | 2.06K | $59.32 | -$102.27K | SELL-OPTIONS | 2.59% | 81.51K | Feb 29 - Mar 01 | View |
| Mar 04, 2024 | Brian Baranick | GEN. MGR., PRECISION ONCOLOGY | 2.40K | $59.32 | -$137.80K | SELL-OPTIONS | 19.76% | 14.55K | Feb 29 - Mar 01 | View |
| Feb 28, 2024 | Jacob A Orville | GENERAL MANAGER, SCREENING | 2.08K | $56.89 | -$106.90K | SELL-OPTIONS | 19.22% | 12.87K | Feb 26 - Feb 27 | View |
| Feb 28, 2024 | James Herriott | GENERAL COUNSEL | 864.00 | $56.89 | -$44.60K | SELL-OPTIONS | 10.27% | 9.28K | Feb 26 - Feb 27 | View |
| Feb 28, 2024 | Everett Cunningham | CHIEF COMMERCIAL OFFICER | 4.03K | $56.89 | -$207.53K | SELL-OPTIONS | 10.12% | 43.87K | Feb 26 - Feb 27 | View |
| Feb 28, 2024 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 2.99K | $56.89 | -$154.17K | SELL-OPTIONS | 44.99% | 9.64K | Feb 26 - Feb 27 | View |
| Feb 28, 2024 | Kevin T Conroy | PRESIDENT AND CEO | 6.92K | $56.89 | -$356.30K | SELL-OPTIONS | 0.53% | 1.31M | Feb 26 - Feb 27 | View |
| Feb 28, 2024 | Sarah Condella | EVP, HUMAN RESOURCES | 2.07K | $56.89 | -$106.95K | SELL-OPTIONS | 2.68% | 79.46K | Feb 26 - Feb 27 | View |
| Feb 28, 2024 | Brian Baranick | GEN. MGR., PRECISION ONCOLOGY | 1.93K | $56.89 | -$115.32K | SELL-OPTIONS | 18.85% | 12.15K | Feb 26 - Feb 27 | View |
| Feb 26, 2024 | Sarah Condella | EVP, HUMAN RESOURCES | -1.02K | $59.72 | -$60.97K | SELL | -1.30% | 77.38K | Feb 23 | View |
| Feb 23, 2024 | Jacob A Orville | GENERAL MANAGER, SCREENING | 1.02K | $59.78 | -$60.56K | GRANT | 10.45% | 10.80K | Feb 21 - Feb 22 | View |
| Feb 23, 2024 | James Herriott | GENERAL COUNSEL | 290.00 | $59.78 | -$17.40K | GRANT | 3.57% | 8.42K | Feb 21 - Feb 22 | View |
| Feb 23, 2024 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 1.36K | $59.78 | -$80.76K | GRANT | 25.72% | 6.65K | Feb 21 - Feb 22 | View |
| Feb 23, 2024 | Everett Cunningham | CHIEF COMMERCIAL OFFICER | 1.36K | $59.78 | -$80.70K | GRANT | 3.54% | 39.84K | Feb 21 - Feb 22 | View |
| Feb 23, 2024 | D. Scott Coward | DIRECTOR | 1.37K | $59.78 | -$39.63K | GRANT | 2.87% | 49.19K | Feb 21 - Feb 22 | View |
| Feb 23, 2024 | Kevin T Conroy | PRESIDENT AND CEO | 11.67K | $59.78 | -$691.36K | GRANT | 0.93% | 1.26M | Feb 21 - Feb 22 | View |
| Feb 23, 2024 | Sarah Condella | EVP, HUMAN RESOURCES | 1.02K | $59.78 | -$60.56K | GRANT | 1.32% | 78.41K | Feb 21 - Feb 22 | View |
| Feb 23, 2024 | Brian Baranick | GEN. MGR., PRECISION ONCOLOGY | 941.00 | $59.78 | -$65.34K | GRANT | 10.14% | 10.22K | Feb 21 - Feb 22 | View |
| Feb 22, 2024 | Jacob A Orville | GENERAL MANAGER, SCREENING | 1.17K | $61.50 | -$66.30K | SELL-OPTIONS | 13.60% | 9.78K | Feb 20 - Feb 21 | View |
| Feb 22, 2024 | James Herriott | GENERAL COUNSEL | 449.00 | $61.50 | -$25.52K | SELL-OPTIONS | 5.85% | 8.13K | Feb 20 - Feb 21 | View |
| Feb 22, 2024 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 1.62K | $61.50 | -$91.82K | SELL-OPTIONS | 44.13% | 5.29K | Feb 20 - Feb 21 | View |
| Feb 22, 2024 | D. Scott Coward | DIRECTOR | 1.54K | $61.50 | -$43.42K | SELL-OPTIONS | 3.33% | 47.82K | Feb 20 - Feb 21 | View |
| Feb 22, 2024 | Kevin T Conroy | PRESIDENT AND CEO | 5.40K | $61.50 | -$305.96K | SELL-OPTIONS | 0.43% | 1.25M | Feb 20 - Feb 21 | View |
| Feb 22, 2024 | Sarah Condella | EVP, HUMAN RESOURCES | 1.17K | $61.50 | -$66.36K | SELL-OPTIONS | 1.53% | 77.38K | Feb 20 - Feb 21 | View |
| Feb 22, 2024 | Brian Baranick | GEN. MGR., PRECISION ONCOLOGY | 834.00 | $61.50 | -$55.04K | SELL-OPTIONS | 9.87% | 9.28K | Feb 20 - Feb 21 | View |
| Feb 16, 2024 | Jacob A Orville | GENERAL MANAGER, SCREENING | 1.06K | $61.43 | -$59.34K | SELL-OPTIONS | 14.71% | 8.30K | Feb 14 - Feb 15 | View |
| Feb 16, 2024 | James Herriott | GENERAL COUNSEL | 530.00 | $45.73 | -$23.82K | SELL-OPTIONS | 7.74% | 7.38K | Oct 31 - Feb 15 | View |
| Feb 16, 2024 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 2.08K | $61.43 | -$115.98K | SELL-OPTIONS | 158.72% | 3.40K | Feb 14 - Feb 15 | View |
| Feb 16, 2024 | D. Scott Coward | DIRECTOR | 2.60K | $61.43 | -$84.53K | SELL-OPTIONS | 5.94% | 46.27K | Feb 14 - Feb 15 | View |
| Feb 16, 2024 | Kevin T Conroy | PRESIDENT AND CEO | 17.05K | $45.73 | -$887.33K | SELL-OPTIONS | 1.39% | 1.25M | May 01 - Feb 15 | View |
| Feb 16, 2024 | Sarah Condella | EVP, HUMAN RESOURCES | 1.07K | $61.43 | -$59.28K | SELL-OPTIONS | 1.42% | 75.91K | Feb 14 - Feb 15 | View |
| Jan 04, 2024 | Sarah Condella | EVP, HUMAN RESOURCES | -2.00K | $73.50 | -$147.00K | SELL | -2.60% | 74.85K | Jan 02 | View |
| Jan 04, 2024 | Brian Baranick | GEN. MGR., PRECISION ONCOLOGY | -879.00 | $73.50 | -$64.61K | SELL | -9.59% | 8.29K | Jan 02 | View |
| Dec 18, 2023 | Sarah Condella | EVP, HUMAN RESOURCES | -2.00K | $70.00 | -$140.00K | SELL | -2.54% | 76.85K | Dec 14 | View |
| Oct 13, 2023 | Everett Cunningham | CHIEF COMMERCIAL OFFICER | 15.21K | $48.25 | -$843.55K | SELL-OPTIONS | 66.19% | 38.18K | May 01 - Oct 12 | View |
| Sep 06, 2023 | Sarah Condella | EVP, HUMAN RESOURCES | -6.89K | $84.36 | -$379.62K | SELL | -8.04% | 78.85K | Sep 01 | View |
| Aug 23, 2023 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | -29.24K | $58.80 | -$2.47M | SELL | -95.70% | 1.31K | May 02 - Aug 21 | View |
| Aug 08, 2023 | Brian Baranick | GEN. MGR., PRECISION ONCOLOGY | 1.36K | $85.04 | -$114.80K | SELL-OPTIONS | 17.45% | 9.17K | Aug 04 - Aug 07 | View |
| Jul 28, 2023 | James Edward Doyle | DIRECTOR | -2.00K | $97.42 | -$194.84K | SELL | -3.70% | 52.11K | Jul 27 | View |
| Jul 21, 2023 | James Herriott | GENERAL COUNSEL | -1.30K | $100.00 | -$130.00K | SELL | -15.96% | 6.84K | Jul 19 | View |
| Jun 12, 2023 | James Edward Doyle | DIRECTOR | 2.20K | $90.51 | -$126.90K | GRANT | 4.23% | 54.11K | Jun 08 - Jun 09 | View |
| Jun 12, 2023 | Katherine S Zanotti | DIRECTOR | 572.00 | $90.51 | -$273.97K | GRANT | 0.89% | 64.63K | Jun 08 - Jun 09 | View |
| Jun 12, 2023 | James Herriott | GENERAL COUNSEL | -1.30K | $90.00 | -$117.00K | SELL | -13.76% | 8.14K | Jun 08 | View |
| May 31, 2023 | James Edward Doyle | DIRECTOR | -2.00K | $80.62 | -$161.24K | SELL | -3.71% | 51.91K | May 26 | View |
| May 12, 2023 | Sarah Condella | EVP, HUMAN RESOURCES | -6.09K | $80.00 | -$486.96K | SELL | -6.63% | 85.74K | May 10 | View |
| May 12, 2023 | Jacob A Orville | GENERAL MANAGER, SCREENING | -5.00K | $80.00 | -$400.00K | SELL | -40.86% | 7.24K | May 10 | View |
| May 12, 2023 | James Herriott | GENERAL COUNSEL | -660.00 | $54.93 | -$84.59K | SELL | -6.53% | 9.45K | May 01 - May 10 | View |
| May 03, 2023 | Sarah Condella | EVP, HUMAN RESOURCES | -291.00 | $46.90 | -$42.50K | SELL | -0.32% | 91.83K | Apr 30 - May 01 | View |
| Apr 05, 2023 | Sarah Condella | EVP, HUMAN RESOURCES | -1.00K | $67.19 | -$67.19K | SELL | -1.07% | 92.12K | Apr 03 | View |
| Mar 07, 2023 | Jacob A Orville | GENERAL MANAGER, SCREENING | -5.00K | $65.00 | -$325.00K | SELL | -29.47% | 11.97K | Mar 03 | View |
| Mar 02, 2023 | Everett Cunningham | CHIEF COMMERCIAL OFFICER | -3.63K | $62.01 | -$224.97K | SELL | -13.78% | 22.70K | Mar 01 | View |
| Mar 02, 2023 | Sarah Condella | EVP, HUMAN RESOURCES | -1.00K | $62.00 | -$62.00K | SELL | -1.07% | 92.85K | Mar 01 | View |
| Mar 01, 2023 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 4.90K | $61.12 | -$258.72K | SELL-OPTIONS | 19.15% | 30.51K | Feb 27 - Feb 28 | View |
| Mar 01, 2023 | James Herriott | GENERAL COUNSEL | -338.00 | $60.43 | -$134.45K | SELL | -3.32% | 9.84K | Feb 27 - Feb 28 | View |
| Mar 01, 2023 | Jacob A Orville | GENERAL MANAGER, SCREENING | -2.88K | $60.29 | -$411.87K | SELL | -14.50% | 16.97K | Feb 27 - Feb 28 | View |
| Mar 01, 2023 | D. Scott Coward | DIRECTOR | 5.04K | $61.12 | -$253.83K | SELL-OPTIONS | 15.67% | 37.20K | Feb 27 - Feb 28 | View |
| Mar 01, 2023 | Sarah Condella | EVP, HUMAN RESOURCES | 3.39K | $61.12 | -$178.71K | SELL-OPTIONS | 3.74% | 93.85K | Feb 27 - Feb 28 | View |
| Mar 01, 2023 | Brian Baranick | GEN. MGR., PRECISION ONCOLOGY | 2.02K | $61.12 | -$118.08K | SELL-OPTIONS | 35.81% | 7.67K | Feb 27 - Feb 28 | View |
| Mar 01, 2023 | Kevin T Conroy | PRESIDENT AND CEO | 12.08K | $61.12 | -$636.63K | SELL-OPTIONS | 0.99% | 1.23M | Feb 27 - Feb 28 | View |
| Feb 23, 2023 | Kevin T Conroy | PRESIDENT AND CEO | 5.61K | $62.72 | -$298.80K | SELL-OPTIONS | 0.46% | 1.22M | Feb 21 - Feb 22 | View |
| Feb 23, 2023 | James Herriott | GENERAL COUNSEL | 467.00 | $62.72 | -$24.96K | SELL-OPTIONS | 4.81% | 10.17K | Feb 21 - Feb 22 | View |
| Feb 23, 2023 | Jacob A Orville | GENERAL MANAGER, SCREENING | 3.19K | $62.72 | -$169.97K | SELL-OPTIONS | 19.13% | 19.85K | Feb 21 - Feb 22 | View |
| Feb 23, 2023 | Sarah Condella | EVP, HUMAN RESOURCES | 1.22K | $62.72 | -$64.79K | SELL-OPTIONS | 1.36% | 90.46K | Feb 21 - Feb 22 | View |
| Feb 23, 2023 | D. Scott Coward | DIRECTOR | 1.24K | $62.72 | -$63.16K | SELL-OPTIONS | 4.01% | 32.16K | Feb 21 - Feb 22 | View |
| Feb 23, 2023 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 1.68K | $62.72 | -$89.69K | SELL-OPTIONS | 7.03% | 25.60K | Feb 21 - Feb 22 | View |
| Feb 23, 2023 | Brian Baranick | GEN. MGR., PRECISION ONCOLOGY | 891.00 | $62.72 | -$52.56K | SELL-OPTIONS | 18.74% | 5.65K | Feb 21 - Feb 22 | View |
| Feb 17, 2023 | Sarah Condella | EVP, HUMAN RESOURCES | -1.08K | $63.91 | -$68.77K | SELL | -1.19% | 89.25K | Feb 16 | View |
| Feb 16, 2023 | James Herriott | GENERAL COUNSEL | 483.00 | $65.59 | -$26.24K | SELL-OPTIONS | 5.24% | 9.71K | Feb 14 - Feb 15 | View |
| Feb 16, 2023 | Sarah Condella | EVP, HUMAN RESOURCES | 1.08K | $65.59 | -$62.57K | SELL-OPTIONS | 1.21% | 90.32K | Feb 14 - Feb 15 | View |
| Feb 16, 2023 | Jacob A Orville | GENERAL MANAGER, SCREENING | 1.08K | $69.59 | -$66.39K | SELL-OPTIONS | 6.90% | 16.66K | Feb 14 - Feb 15 | View |
| Feb 16, 2023 | D. Scott Coward | DIRECTOR | 2.15K | $65.59 | -$119.44K | SELL-OPTIONS | 7.48% | 30.92K | Feb 14 - Feb 15 | View |
| Feb 16, 2023 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 2.11K | $65.59 | -$122.39K | SELL-OPTIONS | 9.65% | 23.92K | Feb 14 - Feb 15 | View |
| Feb 16, 2023 | Kevin T Conroy | PRESIDENT AND CEO | 16.52K | $65.59 | -$958.73K | SELL-OPTIONS | 1.38% | 1.21M | Feb 14 - Feb 15 | View |
| Feb 14, 2023 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 1.42K | $64.55 | -$74.75K | SELL-OPTIONS | 6.97% | 21.82K | Feb 10 - Feb 13 | View |
| Feb 14, 2023 | Kevin T Conroy | PRESIDENT AND CEO | 5.18K | $64.55 | -$292.22K | SELL-OPTIONS | 0.44% | 1.19M | Feb 10 - Feb 13 | View |
| Feb 03, 2023 | Sarah Condella | EVP, HUMAN RESOURCES | -1.00K | $67.93 | -$67.93K | SELL | -1.11% | 89.25K | Feb 01 | View |
| Jan 11, 2023 | Sarah Condella | EVP, HUMAN RESOURCES | -672.00 | $53.70 | -$44.45K | SELL | -0.74% | 90.25K | May 02 - Jan 09 | View |
| Oct 13, 2022 | Everett Cunningham | CHIEF COMMERCIAL OFFICER | 18.65K | $39.39 | -$504.62K | SELL-OPTIONS | ∞ | 18.65K | May 02 - Oct 12 | View |
| Aug 08, 2022 | Brian Baranick | GEN. MGR., PRECISION ONCOLOGY | 1.73K | $47.12 | -$46.37K | SELL-OPTIONS | 57.09% | 4.75K | Aug 04 - Aug 05 | View |
| Jul 28, 2022 | Katherine S Zanotti | DIRECTOR | 0.00 | $27.66 | -$161.10K | SELL-OPTIONS | 0.00% | 64.06K | Jul 26 | View |
| Jul 06, 2022 | Kevin T Conroy | PRESIDENT AND CEO | 321.00 | $44.08 | $15.27K | GRANT | 0.03% | 1.19M | May 02 - Jul 01 | View |
| Jul 01, 2022 | Katherine S Zanotti | DIRECTOR | -1.09K | $40.13 | -$43.58K | SELL | -1.67% | 64.06K | Jun 30 | View |
| Mar 02, 2022 | Sarah Condella | EVP, HUMAN RESOURCES | 3.06K | $76.69 | -$215.96K | SELL-OPTIONS | 3.50% | 90.68K | Feb 28 - Mar 01 | View |
| Mar 02, 2022 | Kevin T Conroy | PRESIDENT AND CEO | 15.59K | $76.69 | -$1.10M | SELL-OPTIONS | 1.66% | 952.71K | Feb 28 - Mar 01 | View |
| Mar 02, 2022 | D. Scott Coward | CHIEF LEGAL OFFICER | 4.38K | $76.69 | -$300.01K | SELL-OPTIONS | 27.26% | 20.43K | Feb 28 - Mar 01 | View |
| Mar 02, 2022 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 4.41K | $76.69 | -$310.59K | SELL-OPTIONS | 27.74% | 20.32K | Feb 28 - Mar 01 | View |
| Mar 01, 2022 | Sarah Condella | SVP, HUMAN RESOURCES | -5.48K | $74.19 | -$406.54K | SELL | -5.89% | 87.62K | Feb 25 | View |
| Feb 25, 2022 | Sarah Condella | SVP, HUMAN RESOURCES | 5.48K | $70.10 | -$330.66K | SELL-OPTIONS | 6.25% | 93.10K | Feb 23 - Feb 24 | View |
| Feb 25, 2022 | Kevin T Conroy | PRESIDENT AND CEO | 31.52K | $70.10 | -$1.90M | SELL-OPTIONS | 3.48% | 937.13K | Feb 23 - Feb 24 | View |
| Feb 25, 2022 | D. Scott Coward | CHIEF ADMINISTRATIVE OFFICER | 6.93K | $70.10 | -$407.63K | SELL-OPTIONS | 76.01% | 16.05K | Feb 23 - Feb 24 | View |
| Feb 25, 2022 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 6.85K | $70.10 | -$413.38K | SELL-OPTIONS | 75.64% | 15.91K | Feb 23 - Feb 24 | View |
| Feb 25, 2022 | Jacob A Orville | GENERAL MANAGER, NEW VENTURES | 5.48K | $70.10 | -$330.66K | SELL-OPTIONS | 55.53% | 15.35K | Feb 23 - Feb 24 | View |
| Feb 24, 2022 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 1.55K | $69.05 | -$107.51K | SELL-OPTIONS | 20.73% | 9.06K | Feb 22 - Feb 23 | View |
| Feb 24, 2022 | Sarah Condella | SVP, HUMAN RESOURCES | 1.12K | $69.05 | -$77.61K | SELL-OPTIONS | 1.30% | 87.62K | Feb 22 - Feb 23 | View |
| Feb 24, 2022 | Kevin T Conroy | PRESIDENT AND CEO | 5.18K | $69.05 | -$358.23K | SELL-OPTIONS | 0.58% | 905.61K | Feb 22 - Feb 23 | View |
| Feb 24, 2022 | Jacob A Orville | GENERAL MANAGER, NEW VENTURES | 1.12K | $69.05 | -$77.68K | SELL-OPTIONS | 12.83% | 9.87K | Feb 22 - Feb 23 | View |
| Feb 24, 2022 | D. Scott Coward | CHIEF ADMINISTRATIVE OFFICER | 1.14K | $69.05 | -$76.58K | SELL-OPTIONS | 14.26% | 9.12K | Feb 22 - Feb 23 | View |
| Feb 23, 2022 | Jacob A Orville | GENERAL MANAGER, NEW VENTURES | 1.90K | $73.42 | $143.31K | SELL-OPTIONS | 27.75% | 8.75K | Feb 18 - Feb 22 | View |
| Feb 16, 2022 | Sarah Condella | SVP, HUMAN RESOURCES | 1.09K | $78.94 | $84.39K | SELL-OPTIONS | 1.28% | 86.50K | Feb 14 - Feb 15 | View |
| Feb 16, 2022 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 2.13K | $78.94 | $164.83K | SELL-OPTIONS | 39.74% | 7.50K | Feb 14 - Feb 15 | View |
| Feb 16, 2022 | Kevin T Conroy | PRESIDENT AND CEO | 207.91K | $49.54 | $3.20M | SELL-OPTIONS | 30.02% | 900.42K | Feb 14 - Feb 15 | View |
| Feb 16, 2022 | Jacob A Orville | GENERAL MANAGER, NEW VENTURES | 1.09K | $78.94 | $84.23K | SELL-OPTIONS | 18.93% | 6.85K | Feb 14 - Feb 15 | View |
| Feb 16, 2022 | D. Scott Coward | CHIEF ADMINISTRATIVE OFFICER | 2.49K | $78.42 | $188.14K | SELL-OPTIONS | 45.26% | 7.98K | Apr 30 - Feb 15 | View |
| Nov 03, 2021 | Kevin T Conroy | PRESIDENT AND CEO | -16.92K | $93.88 | -$1.59M | SELL | -2.41% | 686.11K | Nov 01 | View |
| Oct 05, 2021 | Kevin T Conroy | PRESIDENT AND CEO | -17.08K | $93.64 | -$1.60M | SELL | -2.37% | 703.03K | Oct 01 | View |
| Sep 03, 2021 | Kevin T Conroy | PRESIDENT AND CEO | -18.98K | $104.42 | -$1.98M | SELL | -2.57% | 720.11K | Sep 01 | View |
| Aug 04, 2021 | Kevin T Conroy | PRESIDENT AND CEO | -19.97K | $107.50 | -$2.15M | SELL | -2.63% | 739.09K | Aug 02 | View |
| Aug 02, 2021 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | -38.16K | $107.31 | -$4.25M | SELL | -96.47% | 1.40K | Apr 30 - Jul 29 | View |
| Aug 02, 2021 | Katherine S Zanotti | DIRECTOR | -1.38K | $111.11 | -$153.44K | SELL | -2.27% | 59.54K | Jul 30 | View |
| Aug 02, 2021 | James Edward Doyle | DIRECTOR | -2.64K | $111.17 | -$293.49K | SELL | -8.13% | 29.83K | Jul 30 | View |
| Jul 06, 2021 | Kevin T Conroy | PRESIDENT AND CEO | -7.78K | $123.43 | -$960.78K | SELL | -1.02% | 759.06K | Jul 01 | View |
| Jun 11, 2021 | Sarah Condella | SVP, HUMAN RESOURCES | -3.17K | $66.81 | -$622.96K | SELL | -4.02% | 75.80K | Apr 30 - Jun 10 | View |
| Jun 03, 2021 | Kevin T Conroy | PRESIDENT AND CEO | -12.38K | $111.00 | -$1.37M | SELL | -1.59% | 766.84K | Jun 01 | View |
| Jun 03, 2021 | Thomas Carey | DIRECTOR | -17.00K | $108.11 | -$1.84M | SELL | -76.26% | 5.29K | Jun 02 | View |
| May 05, 2021 | Kevin T Conroy | PRESIDENT AND CEO | -18.91K | $97.91 | -$2.50M | SELL | -2.37% | 779.23K | Apr 30 - May 03 | View |
| Apr 05, 2021 | Kevin T Conroy | PRESIDENT AND CEO | -22.75K | $132.30 | -$3.01M | SELL | -2.77% | 798.14K | Apr 01 | View |
| Mar 15, 2021 | Graham P. Lidgard | CHIEF SCIENCE OFFICER | 0.00 | $78.03 | -$4.49M | SELL-OPTIONS | 0.00% | 43.04K | Mar 11 | View |
| Mar 08, 2021 | Graham P. Lidgard | CHIEF SCIENCE OFFICER | -11.73K | $121.33 | -$1.42M | SELL | -23.39% | 38.43K | Mar 05 | View |
| Mar 05, 2021 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | -2.63K | $135.02 | -$355.37K | SELL | -6.24% | 39.55K | Mar 03 | View |
| Mar 05, 2021 | D. Scott Coward | CHIEF ADMINISTRATIVE OFFICER | -2.66K | $135.02 | -$359.69K | SELL | -32.65% | 5.50K | Mar 03 | View |
| Mar 03, 2021 | Graham P. Lidgard | CHIEF SCIENCE OFFICER | 2.50K | $138.42 | -$349.37K | SELL-OPTIONS | 5.25% | 50.16K | Mar 01 - Mar 02 | View |
| Mar 03, 2021 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 795.00 | $139.24 | -$588.99K | SELL-OPTIONS | 1.92% | 42.14K | Mar 01 - Mar 02 | View |
| Mar 03, 2021 | D. Scott Coward | CHIEF ADMINISTRATIVE OFFICER | 899.00 | $139.23 | -$574.46K | SELL-OPTIONS | 12.59% | 8.04K | Mar 01 - Mar 02 | View |
| Mar 03, 2021 | Kevin T Conroy | PRESIDENT AND CEO | 10.78K | $138.42 | -$1.36M | SELL-OPTIONS | 1.33% | 820.89K | Mar 01 - Mar 02 | View |
| Mar 03, 2021 | Sarah Condella | SVP, HUMAN RESOURCES | 1.85K | $138.42 | -$232.41K | SELL-OPTIONS | 2.40% | 78.85K | Mar 01 - Mar 02 | View |
| Mar 02, 2021 | Michael S Wyzga | DIRECTOR | -8.91K | $78.55 | -$2.20M | SELL | -77.70% | 2.56K | Feb 26 | View |
| Mar 02, 2021 | Graham P. Lidgard | CHIEF SCIENCE OFFICER | 1.66K | $137.44 | -$220.32K | SELL-OPTIONS | 3.61% | 47.66K | Feb 26 - Mar 01 | View |
| Mar 02, 2021 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | -4.97K | $136.91 | -$1.15M | SELL | -10.72% | 41.34K | Feb 26 - Mar 01 | View |
| Mar 02, 2021 | Sarah Condella | SVP, HUMAN RESOURCES | 1.26K | $137.44 | -$150.91K | SELL-OPTIONS | 1.66% | 77.01K | Feb 26 - Mar 01 | View |
| Mar 02, 2021 | James E. Doyle | DIRECTOR | -2.00K | $130.11 | -$260.22K | SELL | -6.16% | 30.46K | Feb 26 | View |
| Mar 02, 2021 | D. Scott Coward | CHIEF ADMINISTRATIVE OFFICER | 1.76K | $90.67 | -$591.74K | SELL-OPTIONS | 32.84% | 7.14K | Feb 26 - Mar 01 | View |
| Mar 02, 2021 | Kevin T Conroy | PRESIDENT AND CEO | -21.98K | $136.88 | -$4.28M | SELL | -2.64% | 810.11K | Feb 26 - Mar 01 | View |
| Mar 01, 2021 | D. Scott Coward | CHIEF ADMINISTRATIVE OFFICER | -6.79K | $132.96 | -$902.53K | SELL | -55.81% | 5.37K | Feb 25 | View |
| Feb 25, 2021 | Graham P. Lidgard | CHIEF SCIENCE OFFICER | 5.73K | $136.30 | -$796.26K | SELL-OPTIONS | 14.24% | 46.00K | Feb 23 - Feb 24 | View |
| Feb 25, 2021 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 4.85K | $136.30 | -$606.40K | SELL-OPTIONS | 11.70% | 46.31K | Feb 23 - Feb 24 | View |
| Feb 25, 2021 | D. Scott Coward | CHIEF ADMINISTRATIVE OFFICER | 6.79K | $79.07 | -$2.98M | SELL-OPTIONS | 126.31% | 12.16K | Feb 23 - Feb 24 | View |
| Feb 25, 2021 | Kevin T Conroy | PRESIDENT AND CEO | 17.91K | $136.30 | -$2.24M | SELL-OPTIONS | 2.20% | 832.09K | Feb 23 - Feb 24 | View |
| Feb 25, 2021 | Sarah Condella | SVP, HUMAN RESOURCES | 2.24K | $136.30 | -$280.37K | SELL-OPTIONS | 3.05% | 75.75K | Feb 23 - Feb 24 | View |
| Feb 22, 2021 | Jacob A Orville | GENERAL MANAGER, NEW VENTURES | 1.95K | $143.38 | -$243.17K | SELL-OPTIONS | 53.03% | 5.64K | Feb 18 - Feb 19 | View |
| Feb 22, 2021 | D. Scott Coward | CHIEF ADMINISTRATIVE OFFICER | -1.98K | $140.79 | -$278.76K | SELL | -26.92% | 5.37K | Feb 18 | View |
| Feb 18, 2021 | Jacob A Orville | GENERAL MANAGER, NEW VENTURES | 997.00 | $142.66 | -$147.37K | SELL-OPTIONS | 37.12% | 3.68K | Feb 16 - Feb 17 | View |
| Feb 18, 2021 | Graham P. Lidgard | CHIEF SCIENCE OFFICER | 1.84K | $142.66 | -$304.01K | SELL-OPTIONS | 4.79% | 40.27K | Feb 16 - Feb 17 | View |
| Feb 18, 2021 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 1.95K | $142.66 | -$288.17K | SELL-OPTIONS | 4.94% | 41.46K | Feb 16 - Feb 17 | View |
| Feb 18, 2021 | D. Scott Coward | CHIEF ADMINISTRATIVE OFFICER | 1.98K | $142.66 | -$284.18K | SELL-OPTIONS | 36.84% | 7.35K | Feb 16 - Feb 17 | View |
| Feb 18, 2021 | Kevin T Conroy | PRESIDENT AND CEO | 15.31K | $142.66 | -$2.26M | SELL-OPTIONS | 1.92% | 814.19K | Feb 16 - Feb 17 | View |
| Feb 18, 2021 | Sarah Condella | SVP, HUMAN RESOURCES | 997.00 | $142.66 | -$147.37K | SELL-OPTIONS | 1.38% | 73.50K | Feb 16 - Feb 17 | View |
| Feb 03, 2021 | Kevin T Conroy | PRESIDENT AND CEO | -66.09K | $138.07 | -$4.19M | SELL | -7.80% | 781.34K | Dec 28 - Feb 01 | View |
| Jan 07, 2021 | Kevin T Conroy | PRESIDENT AND CEO | -31.81K | $128.74 | -$4.10M | SELL | -3.62% | 847.43K | Jan 04 | View |
| Dec 14, 2020 | Katherine S Zanotti | — | -20.00K | $132.06 | -$2.64M | SELL | -25.35% | 58.91K | Dec 14 | View |
| Dec 02, 2020 | Kevin T Conroy | — | -30.58K | $124.56 | -$3.81M | SELL | -3.36% | 879.25K | Dec 01 | View |
| Nov 03, 2020 | Kevin T Conroy | — | -32.82K | $121.11 | -$3.97M | SELL | -3.48% | 909.82K | Nov 02 | View |
| Oct 02, 2020 | Kevin T Conroy | — | -27.43K | $103.55 | -$2.84M | SELL | -2.83% | 942.64K | Oct 01 | View |
| Sep 28, 2020 | Torsten Hoof | — | 0.00 | $60.77 | -$169.31K | OPTION EXERCISE | 0.00% | 2.02K | Sep 24 | View |
| Sep 02, 2020 | Kevin T Conroy | — | -19.93K | $75.03 | -$1.50M | SELL | -2.01% | 970.07K | Sep 01 | View |
| Aug 21, 2020 | Torsten Hoof | — | -6.45K | $64.15 | -$610.35K | OPTION EXERCISE | -76.17% | 2.02K | Aug 19 | View |
| Aug 04, 2020 | Thomas D Carey | — | -15.00K | $51.62 | -$2.73M | OPTION EXERCISE | -40.68% | 21.87K | Jul 31 | View |
| Aug 04, 2020 | Kevin T Conroy | — | -24.70K | $68.12 | -$2.34M | GRANT OR AWARD | -2.43% | 990.00K | Apr 30 - Aug 03 | View |
| Aug 04, 2020 | Jeffrey T. Elliott | — | -30.86K | $57.76 | -$3.37M | OPTION EXERCISE | -43.86% | 39.51K | Jul 31 | View |
| Aug 04, 2020 | Daniel J Levangie | — | 0.00 | $51.65 | -$835.61K | OPTION EXERCISE | 0.00% | 15.02K | Jul 31 | View |
| Aug 04, 2020 | Katherine S Zanotti | — | 0.00 | $51.26 | -$1.80M | OPTION EXERCISE | 0.00% | 78.91K | Jul 31 | View |
| Aug 04, 2020 | James Edward Doyle | — | -2.54K | $94.00 | -$238.67K | SELL | -7.25% | 32.46K | Jul 31 | View |
| Jul 30, 2020 | Jeffrey T. Elliott | — | 10.46K | $94.78 | $969.68K | GRANT OR AWARD | 17.47% | 70.37K | Oct 30 - Jul 29 | View |
| Jul 30, 2020 | Katherine S Zanotti | — | -1.16K | $96.13 | -$111.90K | SELL | -1.45% | 78.91K | Jul 28 | View |
| Apr 06, 2020 | Mark Stenhouse | — | 13.05K | $56.69 | -$677.33K | OPTION EXERCISE | 77.35% | 29.93K | Apr 02 - Apr 03 | View |
| Mar 03, 2020 | James Edward Doyle | — | -2.00K | $77.54 | -$155.08K | SELL | -5.81% | 32.44K | Feb 28 | View |
| Mar 02, 2020 | Jeffrey T. Elliott | — | 2.64K | $80.17 | -$191.05K | OPTION EXERCISE | 4.63% | 59.73K | Feb 27 - Feb 28 | View |
| Mar 02, 2020 | Kevin T Conroy | — | 10.82K | $80.17 | -$781.66K | OPTION EXERCISE | 1.08% | 1.01M | Feb 27 - Feb 28 | View |
| Feb 28, 2020 | Mark Stenhouse | — | 2.21K | $80.27 | -$84.36K | OPTION EXERCISE | 15.08% | 16.87K | Feb 26 - Feb 27 | View |
| Feb 28, 2020 | Jeffrey T. Elliott | — | 1.81K | $80.27 | -$130.60K | OPTION EXERCISE | 3.26% | 57.26K | Feb 26 - Feb 27 | View |
| Feb 28, 2020 | Kevin T Conroy | — | 15.46K | $80.27 | -$1.11M | OPTION EXERCISE | 1.56% | 1.00M | Feb 26 - Feb 27 | View |
| Feb 26, 2020 | Jeffrey T. Elliott | — | 4.39K | $85.11 | -$417.89K | OPTION EXERCISE | 8.60% | 55.45K | Feb 24 - Feb 25 | View |
| Feb 26, 2020 | Kevin T Conroy | — | 16.21K | $85.11 | -$1.54M | OPTION EXERCISE | 1.67% | 988.40K | Feb 24 - Feb 25 | View |
| Feb 21, 2020 | G. Bradley Cole | — | -10.00K | $67.88 | -$2.11M | OPTION EXERCISE | -49.52% | 10.19K | Feb 19 | View |
| Feb 20, 2020 | Jacob A Orville | — | 2.50K | $100.68 | -$116.08K | OPTION EXERCISE | 1299.48% | 2.69K | Feb 18 - Feb 19 | View |
| Jan 17, 2020 | G. Bradley Cole | — | -10.00K | $90.30 | -$903.00K | SELL | -32.27% | 20.99K | Jan 16 | View |
| Nov 25, 2019 | G. Bradley Cole | GENERAL MANAGER - DIAGNOSTICS | -28.02K | $80.38 | -$2.25M | SELL | -39.27% | 43.32K | Nov 21 | View |
| Sep 13, 2019 | Scott C Johnson | SVP - RESEARCH AND DEVELOPMENT | 4.66K | $69.54 | -$362.25K | SELL-OPTIONS | 59.39% | 12.50K | Apr 30 - Sep 12 | View |
| Aug 02, 2019 | Katherine S Zanotti | DIRECTOR | -1.74K | $117.93 | -$205.67K | SELL | -2.20% | 77.51K | Jul 31 | View |
| Aug 02, 2019 | Michael S Wyzga | DIRECTOR | -2.50K | $72.45 | -$522.20K | SELL | -21.90% | 8.91K | Jul 31 | View |
| Aug 02, 2019 | Daniel J Levangie | DIRECTOR | 0.00 | $61.48 | -$4.79M | SELL-OPTIONS | 0.00% | 12.46K | Jul 31 | View |
| Aug 02, 2019 | James Edward Doyle | DIRECTOR | -2.81K | $117.93 | -$331.15K | SELL | -7.54% | 34.44K | Jul 31 | View |
| Aug 02, 2019 | Thomas D Carey | DIRECTOR | -10.00K | $117.65 | -$1.18M | SELL | -22.63% | 34.18K | Jul 31 | View |
| Jul 31, 2019 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 9.27K | $83.10 | -$1.02M | SELL-OPTIONS | 22.29% | 50.88K | Apr 30 - Jul 30 | View |
| Apr 04, 2019 | Mark Stenhouse | PRESIDENT, COLOGUARD | 13.81K | $92.54 | -$1.04M | SELL-OPTIONS | 2082.65% | 14.47K | Apr 02 - Apr 03 | View |
| Mar 12, 2019 | D. Scott Coward | CHIEF ADMINISTRATIVE OFFICER | 3.25K | $87.21 | -$241.93K | SELL-OPTIONS | 3.13% | 106.98K | Mar 09 - Mar 11 | View |
| Mar 12, 2019 | Kevin T Conroy | PRESIDENT AND CEO | 13.17K | $87.21 | -$979.13K | SELL-OPTIONS | 1.33% | 1.00M | Mar 09 - Mar 11 | View |
| Mar 01, 2019 | Katherine S Zanotti | DIRECTOR | -25.00K | $92.81 | -$2.32M | SELL | -24.49% | 77.10K | Feb 28 | View |
| Mar 01, 2019 | Michael S Wyzga | DIRECTOR | -500.00 | $96.00 | -$48.00K | SELL | -5.49% | 8.61K | Feb 28 | View |
| Mar 01, 2019 | Scott C Johnson | SVP - RESEARCH AND DEVELOPMENT | -1.17K | $93.20 | -$108.68K | SELL | -12.94% | 7.84K | Feb 28 | View |
| Mar 01, 2019 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | -2.45K | $93.20 | -$228.07K | SELL | -5.55% | 41.60K | Feb 28 | View |
| Mar 01, 2019 | James E. Doyle | DIRECTOR | -2.00K | $96.00 | -$192.00K | SELL | -5.39% | 35.09K | Feb 28 | View |
| Mar 01, 2019 | D. Scott Coward | CHIEF ADMINISTRATIVE OFFICER | -2.45K | $93.20 | -$228.07K | SELL | -2.30% | 103.73K | Feb 28 | View |
| Mar 01, 2019 | Kevin T Conroy | PRESIDENT AND CEO | -10.01K | $93.20 | -$933.34K | SELL | -1.00% | 990.54K | Feb 28 | View |
| Mar 01, 2019 | Thomas D Carey | DIRECTOR | -7.50K | $96.00 | -$720.00K | SELL | -15.31% | 41.48K | Feb 28 | View |
| Feb 28, 2019 | D. Scott Coward | CHIEF ADMINISTRATIVE OFFICER | 16.62K | $95.07 | -$932.01K | SELL-OPTIONS | 18.56% | 106.17K | Feb 26 - Feb 27 | View |
| Feb 28, 2019 | Kevin T Conroy | PRESIDENT AND CEO | 31.43K | $95.07 | -$871.73K | SELL-OPTIONS | 3.24% | 1.00M | Feb 26 - Feb 27 | View |
| Feb 26, 2019 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 4.86K | $90.55 | -$402.50K | SELL-OPTIONS | 14.21% | 39.03K | Feb 23 - Feb 25 | View |
| Feb 26, 2019 | D. Scott Coward | CHIEF ADMINISTRATIVE OFFICER | 6.71K | $90.55 | -$556.25K | SELL-OPTIONS | 8.10% | 89.55K | Feb 23 - Feb 25 | View |
| Feb 26, 2019 | Kevin T Conroy | PRESIDENT AND CEO | 17.93K | $90.55 | -$1.49M | SELL-OPTIONS | 1.88% | 969.13K | Feb 23 - Feb 25 | View |
| Jan 25, 2019 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 0.00 | $78.90 | -$7.17M | SELL-OPTIONS | 0.00% | 33.99K | Jan 23 - Jan 24 | View |
| Jan 25, 2019 | D. Scott Coward | CHIEF ADMINISTRATIVE OFFICER | 0.00 | $78.21 | -$13.23M | SELL-OPTIONS | 0.00% | 82.65K | Jan 23 - Jan 24 | View |
| Jan 25, 2019 | Kevin T Conroy | PRESIDENT AND CEO | 0.00 | $81.27 | -$24.74M | SELL-OPTIONS | 0.00% | 951.20K | Jan 24 - Jan 25 | View |
| Jan 04, 2019 | D. Scott Coward | CHIEF ADMINISTRATIVE OFFICER | 3.11K | $62.75 | -$99.21K | SELL-OPTIONS | 3.90% | 82.65K | Jan 02 - Jan 03 | View |
| Nov 14, 2018 | Katherine S Zanotti | DIRECTOR | -4.09K | $36.22 | -$502.73K | SELL | -3.86% | 102.10K | Oct 31 - Nov 12 | View |
| Nov 14, 2018 | Kevin T Conroy | PRESIDENT AND CEO | 3.57K | $34.97 | -$11.13M | SELL-OPTIONS | 0.38% | 951.20K | Apr 30 - Nov 12 | View |
| Nov 07, 2018 | Graham Peter Lidgard | CHIEF SCIENCE OFFICER | -38.31K | $75.01 | -$2.87M | SELL | -48.28% | 41.04K | Nov 05 - Nov 07 | View |
| Nov 02, 2018 | Graham Peter Lidgard | CHIEF SCIENCE OFFICER | -79.67K | $71.73 | -$5.71M | SELL | -50.10% | 79.35K | Oct 31 - Nov 01 | View |
| Oct 10, 2018 | Graham Peter Lidgard | CHIEF SCIENCE OFFICER | -54.43K | $37.66 | -$4.00M | SELL | -25.50% | 159.02K | Apr 30 - Oct 08 | View |
| Oct 02, 2018 | D. Scott Coward | CHIEF ADMINISTRATIVE OFFICER | 2.50K | $79.51 | -$174.12K | SELL-OPTIONS | 3.24% | 79.55K | Sep 30 - Oct 01 | View |
| Aug 30, 2018 | Michael S Wyzga | DIRECTOR | -2.47K | $74.85 | -$184.73K | SELL | -21.31% | 9.11K | Aug 28 | View |
| Aug 01, 2018 | Katherine S Zanotti | DIRECTOR | -2.85K | $58.86 | -$167.57K | SELL | -2.61% | 106.20K | Jul 30 | View |
| Aug 01, 2018 | John A Fallon | DIRECTOR | -2.37K | $58.86 | -$139.67K | SELL | -6.57% | 33.77K | Jul 30 | View |
| Aug 01, 2018 | James Edward Doyle | DIRECTOR | -1.32K | $58.86 | -$77.58K | SELL | -3.43% | 37.09K | Jul 30 | View |
| Aug 01, 2018 | Thomas D Carey | DIRECTOR | -3.43K | $58.86 | -$201.71K | SELL | -6.54% | 48.98K | Jul 30 | View |
| Jul 31, 2018 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 11.44K | $35.52 | -$496.85K | SELL-OPTIONS | 52.51% | 33.24K | Apr 30 - Jul 30 | View |
| Jul 03, 2018 | D. Scott Coward | SVP AND GENERAL COUNSEL | 6.36K | $32.52 | -$103.53K | SELL-OPTIONS | 8.99% | 77.05K | Apr 30 - Jul 02 | View |
| May 11, 2018 | Michael S Wyzga | DIRECTOR | -7.40K | $51.53 | -$381.45K | SELL | -40.28% | 10.97K | May 10 | View |
| Apr 13, 2018 | Katherine S Zanotti | DIRECTOR | -7.23K | $45.00 | -$325.44K | SELL | -6.40% | 105.81K | Apr 12 | View |
| Apr 12, 2018 | James Edward Doyle | DIRECTOR | -3.10K | $40.97 | -$126.93K | SELL | -8.09% | 35.18K | Apr 10 | View |
| Apr 12, 2018 | Thomas D Carey | DIRECTOR | -8.45K | $39.73 | -$335.63K | SELL | -13.88% | 52.41K | Apr 10 | View |
| Apr 03, 2018 | D. Scott Coward | SVP AND GENERAL COUNSEL | 2.57K | $40.12 | -$85.12K | SELL-OPTIONS | 3.77% | 70.69K | Mar 31 - Apr 02 | View |
| Mar 13, 2018 | Graham Peter Lidgard | CHIEF SCIENCE OFFICER | 0.00 | $37.68 | -$613.07K | SELL-OPTIONS | 0.00% | 206.29K | Mar 09 - Mar 13 | View |
| Mar 13, 2018 | D. Scott Coward | SVP AND GENERAL COUNSEL | 3.32K | $52.19 | -$141.34K | SELL-OPTIONS | 5.12% | 68.12K | Mar 09 - Mar 12 | View |
| Mar 13, 2018 | Kevin T Conroy | PRESIDENT AND CEO | 12.94K | $52.19 | -$598.09K | SELL-OPTIONS | 1.38% | 947.63K | Mar 09 - Mar 12 | View |
| Mar 13, 2018 | Maneesh Arora | COO | 5.98K | $52.19 | -$276.37K | SELL-OPTIONS | 0.92% | 658.61K | Mar 09 - Mar 12 | View |
| Feb 28, 2018 | Maneesh Arora | COO | 6.64K | $44.10 | -$243.07K | SELL-OPTIONS | 1.03% | 652.63K | Feb 26 - Feb 27 | View |
| Feb 28, 2018 | Graham Peter Lidgard | CHIEF SCIENCE OFFICER | -7.79K | $25.32 | -$1.36M | SELL | -3.56% | 211.15K | Feb 26 - Feb 27 | View |
| Feb 28, 2018 | D. Scott Coward | SVP AND GENERAL COUNSEL | 12.11K | $44.10 | -$409.76K | SELL-OPTIONS | 22.98% | 64.81K | Feb 26 - Feb 27 | View |
| Feb 28, 2018 | Kevin T Conroy | PRESIDENT AND CEO | 10.94K | $44.10 | -$400.63K | SELL-OPTIONS | 1.18% | 934.69K | Feb 26 - Feb 27 | View |
| Feb 27, 2018 | Graham Peter Lidgard | CHIEF SCIENCE OFFICER | 12.65K | $31.06 | -$670.25K | SELL-OPTIONS | 6.13% | 218.94K | Feb 23 - Feb 26 | View |
| Feb 27, 2018 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 6.32K | $42.34 | -$126.25K | SELL-OPTIONS | 40.83% | 21.79K | Feb 23 - Feb 26 | View |
| Feb 27, 2018 | D. Scott Coward | SVP AND GENERAL COUNSEL | 8.43K | $42.34 | -$187.13K | SELL-OPTIONS | 19.04% | 52.70K | Feb 23 - Feb 26 | View |
| Feb 27, 2018 | Kevin T Conroy | PRESIDENT AND CEO | 28.51K | $42.34 | -$1.07M | SELL-OPTIONS | 3.18% | 923.75K | Feb 23 - Feb 26 | View |
| Feb 27, 2018 | Maneesh Arora | COO | 17.52K | $42.34 | -$522.96K | SELL-OPTIONS | 2.79% | 646.00K | Feb 23 - Feb 26 | View |
| Feb 13, 2018 | Kevin T Conroy | PRESIDENT AND CEO | 0.00 | $23.28 | -$4.56M | SELL-OPTIONS | 0.00% | 895.24K | Feb 09 | View |
| Jan 25, 2018 | Kevin T Conroy | PRESIDENT AND CEO | 0.00 | $25.66 | -$5.48M | SELL-OPTIONS | 0.00% | 895.24K | Jan 23 | View |
| Jan 17, 2018 | Kevin T Conroy | PRESIDENT AND CEO | 0.00 | $26.81 | -$6.52M | SELL-OPTIONS | 0.00% | 895.24K | Jan 12 | View |
| Jan 04, 2018 | D. Scott Coward | SVP AND GENERAL COUNSEL | 4.70K | $29.24 | -$77.47K | SELL-OPTIONS | 11.99% | 43.94K | Oct 31 - Jan 03 | View |
| Dec 26, 2017 | Kevin T Conroy | PRESIDENT AND CEO | 0.00 | $26.71 | -$6.39M | SELL-OPTIONS | 0.00% | 895.24K | Dec 22 | View |
| Dec 08, 2017 | Kevin T Conroy | PRESIDENT AND CEO | 0.00 | $27.14 | -$6.41M | SELL-OPTIONS | 0.00% | 895.24K | Dec 06 | View |
| Dec 04, 2017 | Graham Peter Lidgard | CHIEF SCIENCE OFFICER | -45.77K | $58.27 | -$2.67M | SELL | -18.18% | 205.96K | Dec 01 | View |
| Nov 22, 2017 | Kevin T Conroy | PRESIDENT AND CEO | 0.00 | $30.17 | -$7.87M | SELL-OPTIONS | 0.00% | 895.24K | Nov 21 | View |
| Nov 13, 2017 | Kevin T Conroy | PRESIDENT AND CEO | 10.00 | $29.98 | -$8.04M | SELL-OPTIONS | 0.00% | 895.24K | Nov 09 | View |
| Nov 03, 2017 | Graham Peter Lidgard | CHIEF SCIENCE OFFICER | -45.77K | $53.60 | -$2.45M | SELL | -15.39% | 251.73K | Nov 01 | View |
| Oct 03, 2017 | Graham Peter Lidgard | CHIEF SCIENCE OFFICER | -45.77K | $30.56 | -$3.33M | SELL | -13.33% | 297.51K | Oct 02 | View |
| Oct 03, 2017 | D. Scott Coward | SVP AND GENERAL COUNSEL | -24.43K | $47.16 | -$1.37M | SELL | -38.37% | 39.24K | Sep 29 - Oct 02 | View |
| Sep 07, 2017 | Graham Peter Lidgard | CHIEF SCIENCE OFFICER | 42.32K | $25.78 | -$1.82M | SELL-OPTIONS | 14.06% | 343.28K | Sep 05 - Sep 06 | View |
| Sep 05, 2017 | Graham Peter Lidgard | CHIEF SCIENCE OFFICER | -45.77K | $41.49 | -$1.90M | SELL | -13.20% | 300.97K | Sep 01 | View |
| Aug 18, 2017 | Thomas D Carey | DIRECTOR | 2.50K | $37.71 | $94.28K | BUY | 4.28% | 60.86K | Aug 17 | View |
| Aug 01, 2017 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 12.90K | $39.41 | -$230.39K | SELL-OPTIONS | 815.16% | 14.49K | Jul 28 - Jul 31 | View |
| Jul 05, 2017 | D. Scott Coward | SVP AND GENERAL COUNSEL | 6.37K | $20.58 | -$48.14K | SELL-OPTIONS | 11.11% | 63.67K | May 01 - Jul 03 | View |
| Apr 04, 2017 | D. Scott Coward | SVP AND GENERAL COUNSEL | 3.15K | $23.74 | -$36.63K | SELL-OPTIONS | 5.81% | 57.30K | Mar 31 - Apr 03 | View |
| Mar 14, 2017 | Graham Peter Lidgard | CHIEF SCIENCE OFFICER | -2.94K | $21.16 | -$62.32K | SELL | -0.85% | 343.17K | Mar 13 | View |
| Mar 14, 2017 | D. Scott Coward | SVP AND GENERAL COUNSEL | -1.98K | $21.16 | -$41.96K | SELL | -3.53% | 54.15K | Mar 13 | View |
| Mar 14, 2017 | Kevin T Conroy | PRESIDENT AND CEO | -12.06K | $21.16 | -$255.17K | SELL | -1.35% | 882.43K | Mar 13 | View |
| Mar 14, 2017 | Maneesh Arora | COO | -5.57K | $21.16 | -$117.95K | SELL | -0.89% | 621.34K | Mar 13 | View |
| Feb 28, 2017 | Graham Peter Lidgard | CHIEF SCIENCE OFFICER | 8.48K | $21.51 | -$186.43K | SELL-OPTIONS | 2.58% | 337.69K | Feb 24 - Feb 27 | View |
| Feb 28, 2017 | D. Scott Coward | SVP AND GENERAL COUNSEL | 14.35K | $21.48 | -$151.35K | SELL-OPTIONS | 40.14% | 50.11K | Feb 26 - Feb 27 | View |
| Feb 28, 2017 | Kevin T Conroy | PRESIDENT AND CEO | 12.39K | $21.51 | -$583.52K | SELL-OPTIONS | 1.44% | 870.09K | Feb 24 - Feb 27 | View |
| Feb 28, 2017 | Maneesh Arora | COO | 12.04K | $21.50 | -$238.97K | SELL-OPTIONS | 1.99% | 615.64K | Feb 24 - Feb 27 | View |
| Jan 05, 2017 | D. Scott Coward | SVP AND GENERAL COUNSEL | 4.71K | $9.78 | -$11.62K | SELL-OPTIONS | 15.59% | 34.92K | Oct 31 - Jan 03 | View |
| Dec 14, 2016 | David Thompson | DIRECTOR | 10.00K | $13.84 | $138.40K | BUY | 7.91% | 136.38K | Dec 14 | View |
| Nov 15, 2016 | Graham Peter Lidgard | CHIEF SCIENCE OFFICER | 872.00 | $10.17 | -$4.53M | SELL-OPTIONS | 0.34% | 257.26K | Oct 31 - Nov 15 | View |
| Nov 15, 2016 | Kevin T Conroy | PRESIDENT AND CEO | 33.08K | $9.36 | -$9.68M | SELL-OPTIONS | 4.11% | 838.32K | Nov 11 - Nov 15 | View |
| Nov 15, 2016 | Maneesh Arora | COO | 0.00 | $9.15 | -$9.36M | SELL-OPTIONS | 0.00% | 596.38K | Nov 11 - Nov 15 | View |
| Oct 04, 2016 | D. Scott Coward | SVP AND GENERAL COUNSEL | 2.99K | $17.98 | -$30.58K | SELL-OPTIONS | 10.97% | 30.21K | Sep 30 - Oct 03 | View |
| Sep 06, 2016 | Lionel Sterling | DIRECTOR | 5.00K | $18.10 | $90.50K | BUY | 4.30% | 121.25K | Sep 01 | View |
| Aug 05, 2016 | Katherine S Zanotti | DIRECTOR | 3.38K | $17.93 | $60.61K | BUY | 3.30% | 105.93K | Aug 03 | View |
| Jul 27, 2016 | Graham Peter Lidgard | CHIEF SCIENCE OFFICER | 20.08K | $10.38 | -$94.76K | SELL-OPTIONS | 8.50% | 256.38K | May 02 - Jul 26 | View |
| Jul 27, 2016 | Maneesh Arora | COO | 17.64K | $14.82 | -$109.06K | SELL-OPTIONS | 3.05% | 596.38K | Jul 25 - Jul 26 | View |
| Jul 05, 2016 | D. Scott Coward | SVP AND GENERAL COUNSEL | 5.37K | $9.12 | -$6.35K | SELL-OPTIONS | 24.56% | 27.22K | May 02 - Jul 01 | View |
| Apr 04, 2016 | D. Scott Coward | SVP AND GENERAL COUNSEL | 3.00K | $6.62 | -$11.15K | SELL-OPTIONS | 15.93% | 21.85K | Mar 31 - Apr 01 | View |
| Mar 11, 2016 | D. Scott Coward | SVP AND GENERAL COUNSEL | 3.85K | $6.05 | -$13.16K | SELL-OPTIONS | 25.67% | 18.85K | Mar 09 - Mar 10 | View |
| Mar 11, 2016 | Graham Peter Lidgard | CHIEF SCIENCE OFFICER | 5.38K | $6.05 | -$18.40K | SELL-OPTIONS | 2.33% | 236.30K | Mar 09 - Mar 10 | View |
| Mar 11, 2016 | Maneesh Arora | COO | 7.23K | $6.05 | -$24.45K | SELL-OPTIONS | 2.21% | 334.17K | Mar 09 - Mar 10 | View |
| Mar 08, 2016 | James Edward Doyle | DIRECTOR | 5.00K | $6.43 | $32.15K | BUY | 30.38% | 21.46K | Mar 08 | View |
| Mar 04, 2016 | Katherine S Napier | DIRECTOR | 3.77K | $5.38 | $20.30K | BUY | 4.33% | 91.00K | Mar 03 | View |
| Mar 01, 2016 | Kevin T Conroy | PRESIDENT AND CEO | 50.00K | $5.00 | $250.00K | BUY | 7.11% | 753.10K | Mar 01 | View |
| Feb 29, 2016 | Kevin T Conroy | PRESIDENT AND CEO | -6.89K | $5.81 | -$40.06K | SELL | -0.97% | 703.10K | Feb 26 | View |
| Feb 26, 2016 | Graham Peter Lidgard | CHIEF SCIENCE OFFICER | 5.25K | $5.52 | -$16.54K | SELL-OPTIONS | 2.33% | 230.92K | Feb 24 - Feb 25 | View |
| Feb 26, 2016 | Maneesh Arora | COO | 6.90K | $5.52 | -$22.63K | SELL-OPTIONS | 2.16% | 326.94K | Feb 24 - Feb 25 | View |
| Feb 24, 2016 | Graham P. Lidgard | CHIEF SCIENCE OFFICER | 4.81K | $6.39 | -$15.41K | SELL-OPTIONS | 2.18% | 225.67K | Feb 22 - Feb 23 | View |
| Feb 24, 2016 | Kevin T Conroy | PRESIDENT AND CEO | 12.51K | $6.39 | -$43.87K | SELL-OPTIONS | 1.85% | 690.49K | Feb 22 - Feb 23 | View |
| Feb 24, 2016 | Maneesh Arora | COO | 4.67K | $6.39 | -$16.33K | SELL-OPTIONS | 1.48% | 320.03K | Feb 22 - Feb 23 | View |
| Jan 13, 2016 | David Thompson | DIRECTOR | 15.00K | $6.99 | $104.85K | BUY | 15.75% | 110.21K | Jan 11 | View |
| Jan 06, 2016 | D. Scott Coward | SVP AND GENERAL COUNSEL | 11.68K | $9.05 | -$64.02K | SELL-OPTIONS | 1459.50% | 12.48K | Jan 04 - Jan 05 | View |
| Jan 05, 2016 | Kevin T Conroy | PRESIDENT AND CEO | 7.19K | $8.72 | -$93.74K | SELL-OPTIONS | 1.78% | 412.06K | Feb 18 - Jan 04 | View |
| Jan 05, 2016 | Maneesh Arora | COO | 3.12K | $8.72 | -$30.08K | SELL-OPTIONS | 1.26% | 250.37K | Dec 31 - Jan 04 | View |
| Jan 05, 2016 | Graham Peter Lidgard | CHIEF SCIENCE OFFICER | 4.34K | $8.22 | -$20.62K | SELL-OPTIONS | 2.03% | 218.33K | Nov 01 - Jan 04 | View |
| Jul 28, 2015 | Graham Peter Lidgard | CHIEF SCIENCE OFFICER | 13.40K | $20.91 | -$284.94K | SELL-OPTIONS | 6.68% | 213.99K | Apr 30 - Jul 27 | View |
| Jul 28, 2015 | Maneesh Arora | COO | 15.67K | $24.04 | -$224.34K | SELL-OPTIONS | 8.63% | 197.25K | Jul 25 - Jul 27 | View |
| Jul 28, 2015 | Kevin T Conroy | PRESIDENT AND CEO | 14.81K | $20.91 | -$252.47K | SELL-OPTIONS | 4.81% | 322.52K | Apr 30 - Jul 27 | View |
| Feb 26, 2015 | Graham P. Lidgard | DIRECTOR | 4.31K | $23.44 | -$92.31K | SELL-OPTIONS | 2.19% | 200.77K | Feb 24 - Feb 26 | View |
| Feb 26, 2015 | Kevin T Conroy | PRESIDENT AND CEO | 11.07K | $23.44 | -$197.48K | SELL-OPTIONS | 4.40% | 262.58K | Feb 24 - Feb 26 | View |
| Feb 26, 2015 | Maneesh Arora | COO | 7.11K | $23.44 | -$91.30K | SELL-OPTIONS | 5.94% | 126.72K | Feb 24 - Feb 26 | View |
| Feb 25, 2015 | Graham P. Lidgard | DIRECTOR | 3.19K | $22.90 | -$92.45K | SELL-OPTIONS | 1.65% | 196.45K | Feb 23 - Feb 24 | View |
| Feb 25, 2015 | Kevin T Conroy | PRESIDENT AND CEO | 9.58K | $22.90 | -$224.37K | SELL-OPTIONS | 3.96% | 251.51K | Feb 23 - Feb 24 | View |
| Feb 25, 2015 | Maneesh Arora | COO | 4.23K | $22.90 | -$68.59K | SELL-OPTIONS | 3.67% | 119.62K | Feb 23 - Feb 24 | View |
| Jan 05, 2015 | Graham P. Lidgard | CHIEF SCIENCE OFFICER | -337.00 | $17.27 | -$86.27K | SELL | -0.17% | 195.83K | Oct 31 - Jan 02 | View |
| Jan 05, 2015 | Maneesh Arora | COO | 5.35K | $17.27 | -$56.67K | SELL-OPTIONS | 4.86% | 115.39K | May 08 - Jan 02 | View |
| Jan 05, 2015 | Kevin T Conroy | PRESIDENT AND CEO | 7.84K | $26.72 | -$253.41K | SELL-OPTIONS | 3.35% | 241.93K | Mar 14 - Jan 02 | View |
| Oct 29, 2014 | Graham P. Lidgard | CHIEF SCIENCE OFFICER | -8.02K | $24.68 | -$197.81K | SELL | -3.93% | 196.16K | Oct 29 | View |
| Oct 20, 2014 | Sally Crawford | DIRECTOR | 0.00 | $13.85 | -$1.61M | SELL-OPTIONS | 0.00% | 212.34K | Oct 16 - Oct 20 | View |
| Oct 20, 2014 | Graham P. Lidgard | CHIEF SCIENCE OFFICER | 75.00K | $13.18 | -$2.87M | SELL-OPTIONS | 58.06% | 204.18K | Oct 16 - Oct 20 | View |
| Oct 20, 2014 | Maneesh Arora | COO | 80.00K | $12.16 | -$5.54M | SELL-OPTIONS | 84.18% | 175.04K | Oct 16 - Oct 20 | View |
| Oct 20, 2014 | Kevin T Conroy | PRESIDENT AND CEO | 135.00K | $12.16 | -$8.95M | SELL-OPTIONS | 82.27% | 299.09K | Oct 16 - Oct 20 | View |
| Jul 29, 2014 | Graham P. Lidgard | SR. VP, CHIEF SCIENCE OFFICER | 15.15K | $11.90 | -$167.60K | SELL-OPTIONS | 13.28% | 129.18K | Oct 31 - Jul 25 | View |
| Jul 29, 2014 | Maneesh Arora | COO | 19.04K | $11.90 | -$122.56K | SELL-OPTIONS | 25.05% | 95.04K | Oct 31 - Jul 25 | View |
| Jul 29, 2014 | Kevin T Conroy | PRESIDENT AND CEO | 16.39K | $11.90 | -$160.01K | SELL-OPTIONS | 11.09% | 164.09K | Apr 30 - Jul 25 | View |
| May 06, 2014 | William Megan | SVP, FINANCE & PFO | 12.52K | $11.29 | $141.43K | BUY | 317.82% | 16.46K | Apr 30 - May 05 | View |
| Feb 25, 2014 | Graham Lidgard | SR. VP, CHIEF SCIENCE OFFICER | 4.07K | $14.07 | -$44.46K | SELL-OPTIONS | 3.58% | 117.61K | Feb 22 - Feb 24 | View |
| Feb 25, 2014 | Maneesh Arora | COO | 4.56K | $14.07 | -$37.45K | SELL-OPTIONS | 6.39% | 76.00K | Feb 22 - Feb 24 | View |
| Feb 25, 2014 | Kevin Conroy | PRESIDENT AND CEO | 10.67K | $14.07 | -$122.52K | SELL-OPTIONS | 7.51% | 152.63K | Feb 22 - Feb 24 | View |
| Jan 03, 2014 | Graham Lidgard | SR. VP, CHIEF SCIENCE OFFICER | 6.95K | $11.96 | -$123.04K | SELL-OPTIONS | 6.62% | 111.90K | Nov 18 - Jan 02 | View |
| Jan 03, 2014 | Maneesh Arora | COO | 1.47K | $11.96 | -$103.18K | SELL-OPTIONS | 2.14% | 70.18K | Dec 31 - Jan 02 | View |
| Jan 03, 2014 | Kevin Conroy | PRESIDENT AND CEO | 31.86K | $11.96 | -$315.49K | SELL-OPTIONS | 29.36% | 140.37K | Dec 31 - Jan 02 | View |
| Oct 30, 2013 | Graham Lidgard | SR. VP, CHIEF SCIENCE OFFICER | -7.43K | $11.07 | -$82.25K | SELL | -6.61% | 104.95K | Oct 28 | View |
| Sep 24, 2013 | Sally Crawford | DIRECTOR | 0.00 | $8.04 | -$207.50K | SELL-OPTIONS | 0.00% | 203.87K | Sep 20 | View |
| Nov 02, 2012 | Kevin Conroy | PRESIDENT AND CEO | 4.70K | $6.42 | $50.07K | BUY | 6.11% | 81.48K | Mar 05 - Nov 02 | View |
| Nov 02, 2012 | Maneesh Arora | COO AND CFO | 5.20K | $6.16 | $32.06K | BUY | 14.35% | 41.44K | Apr 30 - Nov 02 | View |
| Nov 02, 2012 | Lionel Sterling | DIRECTOR | 5.50K | $9.08 | $49.94K | BUY | 8.36% | 71.27K | Nov 01 | View |
| Apr 24, 2012 | David Thompson | DIRECTOR | 20.00K | $8.16 | $163.28K | BUY | 72.81% | 47.47K | Dec 13 | View |
| Nov 23, 2010 | Kevin T Conroy | PRESIDENT AND CEO | 6.00K | $5.62 | $33.72K | BUY | 13.73% | 49.69K | Nov 23 | View |
| Aug 20, 2010 | Maneesh Arora | SENIOR VP AND CFO | -2.50K | $4.14 | -$10.35K | p | -12.27% | 17.88K | Aug 20 | View |
| Aug 19, 2010 | Lionel Sterling | DIRECTOR | 2.00K | $4.27 | $8.55K | BUY | 3.35% | 61.78K | Aug 17 | View |
| Aug 17, 2010 | Lionel Sterling | DIRECTOR | 5.00K | $4.32 | $21.60K | BUY | 9.13% | 59.78K | Aug 13 | View |
| Aug 09, 2010 | Daniel J Levangie | DIRECTOR | 50.00K | $4.25 | $212.50K | BUY | 857.49% | 55.83K | Aug 06 | View |
| Aug 05, 2010 | Kevin T Conroy | PRESIDENT AND CEO | 4.00K | $4.26 | $17.04K | BUY | 10.08% | 43.69K | Aug 04 | View |
| May 12, 2010 | Kevin T Conroy | PRESIDENT AND CEO | 3.58K | $4.22 | $15.11K | BUY | 9.91% | 39.69K | May 10 | View |
| Feb 18, 2010 | MANEESH ARORA | SR. VP & CFO | 2.50K | $3.98 | $9.96K | BUY | 45.83% | 7.96K | Feb 18 | View |
| Sep 01, 2009 | Kevin Conroy | PRESIDENT & CEO | 9.00K | $2.22 | $19.98K | BUY | ∞ | 9.00K | Aug 31 | View |
| Nov 05, 2003 | ANTHONY SHUBER | EXECUTIVE VICE PRESIDENT | -50.00K | $10.52 | -$526.13K | SELL | -61.73% | 31.00K | Nov 03 | View |
FAQ
Q
Est-ce que le trading d'initiés est légal ?
A
Le trading d'initiés est légal tant que les initiés signalent ces transactions à la SEC. Le trading de titres illégal se produit lorsque l'initié enfreint un devoir fiduciaire ou omet de signaler ses transactions.
Q
Quels sont quelques exemples de manipulation de marché ?
A
Le trading d'initiés, les schémas de gonflement et de vidage, le front running et les opérations de lavage sont tous des exemples de manipulation de marché. Les investisseurs qui suivent les mouvements d'actifs des initiés devraient réfléchir attentivement à la raison pour laquelle ces initiés échangent leurs actions avant de passer à l'action.
Parcourir transactions d'initiés sur toutes les actions.
Actualités sur les transactions d'initiés de EXAS
Les gens regardent aussi
PARTENAIRE / CONTRIBUTEUR
© 2026 Benzinga | All Rights Reserved